Clinical significance of subclinical carotid atherosclerosis and its relationship with echocardiographic parameters in non-diabetic chronic kidney disease patients

BMC Cardiovascular Disorders

Volumn 13, Issue , 2013, Pages

  Kim, Jwa Kyung ^a   Song, Young R ^a   Kim, Min G ^a   Kim, Hyung J ^a   Kim, Sung G ^a  

^a Hallym University College of Medicine   (South Korea)

Author keywords

Cardiovascular events; Carotid atherosclerosis; Increased left ventricular filling pressure; Non diabetic chronic kidney disease

Indexed keywords

ANTIBIOTIC AGENT; C REACTIVE PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ARTERIAL WALL THICKNESS; ARTICLE; CAROTID ATHEROSCLEROSIS; CHRONIC KIDNEY DISEASE; DIAGNOSTIC TEST; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FLOW RATE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PULSE PRESSURE; RISK FACTOR;

AGED; AGED, 80 AND OVER; CAROTID ARTERY DISEASES; COHORT STUDIES; DIABETES MELLITUS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 84887123196     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-13-96     Document Type: Article

References (30)

1. Rubin MF, Rosas SE, Chirinos JA, Townsend RR. Surrogate markers of cardiovascular disease in CKD: what's under the hood?. Am J Kidney Dis 2011, 57:488-497. 10.1053/j.ajkd.2010.08.030, 21168944.
2. Simon A, Megnien JL, Chironi G. The value of carotid intima-media thickness for predicting cardiovascular risk. Arterioscler Thromb Vasc Biol 2010, 30:182-185. 10.1161/ATVBAHA.109.196980, 19948842.
3. Kato A, Takita T, Maruyama Y, Kumagai H, Hishida A. Impact of carotid atherosclerosis on long-term mortality in chronic hemodialysis patients. Kidney Int 2003, 64:1472-1479. 10.1046/j.1523-1755.2003.00205.x, 12969168.
4. Benedetto FA, Mallamaci F, Tripepi G, Zoccali C. Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol 2001, 12:2458-2464.
5. Fernandes VR, Polak JF, Edvardsen T, Carvalho B, Gomes A, Bluemke DA, Nasir K, O'Leary DH, Lima JA. Subclinical atherosclerosis and incipient regional myocardial dysfunction in asymptomatic individuals: the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 2006, 47:2420-2428. 10.1016/j.jacc.2005.12.075, 16781369.
6. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L, Desvarieux M, Ebrahim S, Fatar M, Hernandez Hernandez R, Jaff M, Kownator S, Prati P, Rundek T, Sitzer M, Schminke U, Tardif JC, Taylor A, Vicaut E, Woo KS, Zannad F, Zureik M. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007, 23:75-80. 10.1159/000097034, 17108679.
7. Nagai Y, Metter EJ, Earley CJ, Kemper MK, Becker LC, Lakatta EG, Fleq JL. Increased carotid artery intimal-medial thickness in asymptomatic older subjects with exercise-induced myocardial ischemia. Circulation 1998, 98:1504-1509. 10.1161/01.CIR.98.15.1504, 9769303.
8. Parrinello G, Colomba D, Bologna P, Licata A, Pinto A, Paterna S, Scaqlione R, Licata G. Early carotid atherosclerosis and cardiac diastolic abnormalities in hypertensive subjects. J Hum Hypertens 2004, 18:201-205. 10.1038/sj.jhh.1001653, 14973515.
9. Pauletto P, Palatini P, da Ros S, Pagliara V, Santipolo N, Baccillieri S, Casliqlia E, Mormino P, Pessna AC. Factors underlying the increase in carotid intima-media thickness in borderline hypertensives. Arterioscler Thromb Vasc Biol 1999, 19:1231-1237. 10.1161/01.ATV.19.5.1231, 10323774.
10. Komorovsky R, Desideri A. Carotid ultrasound assessment of patients with coronary artery disease: a useful index for risk stratification. Vasc Health Risk Manag 2005, 1:131-136. 10.2147/vhrm.1.2.131.64077, 1993944, 17315399.
11. Finn AV, Kolodgie FD, Virmani R. Correlation between carotid intimal/medial thickness and atherosclerosis: a point of view from pathology. Arterioscler Thromb Vasc Biol 2010, 30:177-181. 10.1161/ATVBAHA.108.173609, 19679833.
12. Spence JD. Technology Insight: ultrasound measurement of carotid plaque-patient management, genetic research, and therapy evaluation. Nat Clin Pract Neurol 2006, 2:611-619. 10.1038/ncpneuro0324, 17057748.
13. Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, Snapinn S, Harris KE, Aurup P, Edelman JM, Wedel H, Lindholm LH, Dahlof B. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA 2004, 292:2343-2349. 10.1001/jama.292.19.2343, 15547161.
14. Fagard RH, Staessen JA, Thijs L, Celis H, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Leonetti G, Sarti C, Tuomilehto J, Webster J, Yodfat Y. Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension. Hypertension 2004, 44:459-464. 10.1161/01.HYP.0000142169.17298.54, 15326091.
15. Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris K, Aurup P, Dahlof B. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 2004, 292:2350-2356. 10.1001/jama.292.19.2350, 15547162.
16. Zanchetti A, Hennig M, Hollweck R, Baurecht H, Bond G, Tang R, Cuspidi C, Parati G, Facchetti R, Mancia G. Baseline values but not treatment induced changes in carotid intima media thickness predict incident cardiovascular events in treated hypertensives. Findings in the ELSA. Circulation 2009, 120:1084-1090. 10.1161/CIRCULATIONAHA.108.773119, 19738145.
17. Inaba Y, Chen JA, Bergmann SR. Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: a meta-analysis. Atherosclerosis 2012, 220:128-133. 10.1016/j.atherosclerosis.2011.06.044, 21764060.
18. Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T. SHARP Investigators The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomized placebo-controlled trial. Lancet 2011, 377:2181-2192. 10.1016/S0140-6736(11)60739-3, 3145073, 21663949, SHARP Investigators.
19. Wanner C, Krane V, März W, Olschewski M, Mann JF, Ruf G, Ritz E, Ritz E. German Diabetes and Dialysis Study Investigators Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Eng J Med 2005, 353:238-248. German Diabetes and Dialysis Study Investigators.
20. Fellström BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J, Chae DW, Chevaile A, Cobbe SM, Grönhagen-Riska C, de Lima JJ, Lins R, Mayer G, McMahon AW, Parving HH, Remuzzi G, Samuelsson O, Sonkodi S, Sci D, Süleymanlar G, Tsakiris D, Tesar V, Todorov V, Wiecek A, Wüthrich RP, Gottlow M, Johnsson E, Zannad F. AURORA Study Group Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009, 360:1395-1407. 10.1056/NEJMoa0810177, 19332456, AURORA Study Group.
21. Zaslavsky LM, Pinotti AF, Gross JL. Diastolic dysfunction and mortality in diabetic patients on hemodialysis: a 4.25-year controlled prospective study. J Diabetes Complications 2005, 19:194-200. 10.1016/j.jdiacomp.2004.12.001, 15993352.
22. Wang AY, Sanderson JE. Current perspectives on diagnosis of heart failure in long-term dialysis patients. Am J Kidney Dis 2011, 57:308-319. 10.1053/j.ajkd.2010.07.019, 21056523.
23. Kim SJ, Han SH, Park JT, Kim JK, Oh HJ, Yoo DE, Yoo TH, Kang SW, Choi KH. Left atrial volume is an independent predictor of mortality in CAPD patients. Nephrol Dial Transplant 2011, 26:3732-3739. 10.1093/ndt/gfr118, 21430181.
24. Wang AY, Wang M, Lam CW, Chan IH, Zhang Y, Sanderson JE. Left ventricular filling pressure by Doppler echocardiography in patients with end-stage renal disease. Hypertension 2008, 52:107-114. 10.1161/HYPERTENSIONAHA.108.112334, 18474835.
25. Harma R, Pellerin D, Gaze DC, Mehta RL, Gregson H, Streather CP, Collinson PO, Brecker SJ. Mitral peak Doppler E-wave to peak mitral annulus velocity ratio is an accurate estimate of left ventricular filling pressure and predicts mortality in end-stage renal disease. J Am Soc Echocardiogra 2006, 19:266-273.
26. Munakata M, Sakuraba J, Tayama J, Furuta T, Yusa A, Nunokawa T, Yoshinaga K, Toyota T. Higher brachial-ankle pulse wave velocity is associated with more advanced carotid atherosclerosis in end-stage renal disease. Hypertens Res 2005, 28:9-14. 10.1291/hypres.28.9, 15969249.
27. Yambe M, Tomiyama H, Hirayama Y, Gulniza Z, Takata Y, Koji Y, Motobe K, Yamashina A. Arterial stiffening as a possible risk factor for both atherosclerosis and diastolic heart failure. Hypertens Res 2004, 27:625-631. 10.1291/hypres.27.625, 15750255.
28. Recio-Mayoral A, Banerjee D, Streather C, Kaski JC. Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease-a cross-sectional study of predialysis, dialysis and kidney-transplantation patients. Atherosclerosis 2011, 216:446-451. 10.1016/j.atherosclerosis.2011.02.017, 21414625.
29. Lee JK, Lin HH, Tsai CT, Chen JJ, Kuo CC, Lien YC, Lin JW, Huang JW, Hwang SW, Hwang JJ, Tseng CD, Chiang FT, Chen JJ, Wu CK. Differential association of proinflammatory cytokines with left ventricular diastolic dysfunction in subjects with and without continuous ambulatory peritoneal dialysis. Nutr Metab Cardiovasc Dis 2012, 22:974-980. 10.1016/j.numecd.2011.01.001, 21592755.
30. Prabhu SD. Cytokine-induced modulation of cardiac function. Circ Res 2004, 95:1140-1153. 10.1161/01.RES.0000150734.79804.92, 15591236.